Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Du

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
International Journal of Clinical Pharmacy|July 4, 2026
Validation of an updated French national tool for reporting pharmacist interventions for all healthcare productsRémi Toth, Eléonore Martin, Cordélia Salomez-Ihl, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trialMarie Véron, Sylvie Chevret, Jean-Jacques Grob, et al.
Hematological Oncology|July 12, 2025
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell LymphomaJuliette Penichoux, Pierre Decazes, Cédric Rossi, et al.
JAMA Neurology|March 24, 2020
Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical TrialClaire André, Stéphane Rehel, Elizabeth Kuhn, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Blood|October 25, 2017
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphomaThierry Lamy, Gandhi Damaj, Pierre Soubeyran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFTPrudence A Francis, Gini F Fleming, István Láng, et al.
Blood Advances|August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Cédric Rossi, Pierre Sesques, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
International Journal of Clinical Pharmacy|July 4, 2026
Validation of an updated French national tool for reporting pharmacist interventions for all healthcare productsRémi Toth, Eléonore Martin, Cordélia Salomez-Ihl, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trialMarie Véron, Sylvie Chevret, Jean-Jacques Grob, et al.
Hematological Oncology|July 12, 2025
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell LymphomaJuliette Penichoux, Pierre Decazes, Cédric Rossi, et al.
JAMA Neurology|March 24, 2020
Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical TrialClaire André, Stéphane Rehel, Elizabeth Kuhn, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Blood|October 25, 2017
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphomaThierry Lamy, Gandhi Damaj, Pierre Soubeyran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFTPrudence A Francis, Gini F Fleming, István Láng, et al.
Blood Advances|August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Cédric Rossi, Pierre Sesques, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Pageof 31